309. 進行性ミオクローヌスてんかん Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 14 / 薬物数 : 16 - (DrugBank : 5) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 16

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Brivaracetam
   UCB Pharma S.A.
      2006   -   EUCTR2006-000169-12-SE   Finland;France;Italy;Netherlands;Sweden
   UCB S.A.
      2006   Phase 3   EUCTR2006-001536-46-FR   Finland;France
      2006   Phase 3   EUCTR2006-001536-46-FI   Finland;France
      2006   -   EUCTR2006-000169-12-NL   Finland;France;Italy;Netherlands;Sweden
      2006   Phase 3   EUCTR2006-000169-12-FR   Finland;France;Italy;Netherlands;Sweden
      2006   -   EUCTR2006-000169-12-FI   Finland;France;Italy;Netherlands;Sweden
   UCB S.A. Casa Madre
      2007   -   EUCTR2006-000169-12-IT   Finland;France;Italy;Netherlands;Sweden
Brivaracetam 25 MG
   UCB Pharma SA
      2006   Phase 3   NCT00357669   Finland;France;Italy;Netherlands;Réunion;Sweden;Tunisia
Brivaracetam 50 MG
   UCB Pharma SA
      2006   Phase 3   NCT00357669   Finland;France;Italy;Netherlands;Réunion;Sweden;Tunisia
BRV 2.5 MG
   UCB Pharma
      2006   Phase 3   NCT00368251   Canada;Finland;Former Serbia and Montenegro;France;Israel;Russian Federation;Serbia;Tunisia;United States
BRV 25 MG
   UCB Pharma
      2006   Phase 3   NCT00368251   Canada;Finland;Former Serbia and Montenegro;France;Israel;Russian Federation;Serbia;Tunisia;United States
BRV 50 MG
   UCB Pharma
      2006   Phase 3   NCT00368251   Canada;Finland;Former Serbia and Montenegro;France;Israel;Russian Federation;Serbia;Tunisia;United States
Cetirizina
   AZIENDA USL DI BOLOGNA
      2023   Phase 2   EUCTR2023-000185-34-IT   Italy
Clervonafusp alfa
   AZIENDA USL DI BOLOGNA
      2023   Phase 2   EUCTR2023-000185-34-IT   Italy
Intravenous immunoglobulin
   Azienda Socio Sanitaria Territoriale di Mantova
      2015   Phase 3   NCT03351569   -
ION283
   Berge Minassian
      2024   Phase 1/Phase 2   NCT06609889   United States
J06ba02
   AZIENDA SOCIO SANITARIA TERRITORIALE DI MANTOVA
      -   Phase 3   EUCTR2017-002147-15-IT   Italy
Paracetamolo
   AZIENDA USL DI BOLOGNA
      2023   Phase 2   EUCTR2023-000185-34-IT   Italy
Requip
   Department of Neurology, Turku University Hospital
      2007   -   EUCTR2007-003210-33-FI   Finland
Ropinirole hydrochloride
   Department of Neurology, Turku University Hospital
      2007   -   EUCTR2007-003210-33-FI   Finland
UCB 34714
   UCB Pharma S.A.
      2006   -   EUCTR2006-000169-12-SE   Finland;France;Italy;Netherlands;Sweden
   UCB S.A.
      2006   Phase 3   EUCTR2006-001536-46-FR   Finland;France
      2006   Phase 3   EUCTR2006-001536-46-FI   Finland;France
      2006   -   EUCTR2006-000169-12-NL   Finland;France;Italy;Netherlands;Sweden
      2006   Phase 3   EUCTR2006-000169-12-FR   Finland;France;Italy;Netherlands;Sweden
      2006   -   EUCTR2006-000169-12-FI   Finland;France;Italy;Netherlands;Sweden
VAL-1221
   AZIENDA USL DI BOLOGNA
      2023   Phase 2   EUCTR2023-000185-34-IT   Italy